Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Preseasonal Omalizumab Treatment in Seasonal Allergic Rhinitis Patients

NCT04489121 is registered in ClinicalTrials.gov with Beijing Tongren Hospital as lead sponsor.

NCT NCT04489121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04489121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Preseasonal Omalizumab Treatment in Seasonal Allergic Rhinitis Patients
Lead sponsor
Beijing Tongren Hospital
Phase
Not applicable
Overall status
Completed
Start date
July 28, 2020
Completion date
October 1, 2020
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

seasonal allergic rhinitis